Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102066183 | 10206618 | 3 | F | 20160817 | 20140530 | 20160822 | EXP | US-GLAXOSMITHKLINE-A1068125A | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102066183 | 10206618 | 1 | PS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 53 NG/KG/MIN AT 60,000 NG/ML CONCENTRATION 1.5 VIAL STRENGTH, 74 ML/DAY | U | R852 | 20444 | 53 | DF | POWDER FOR INFUSION | |||||
| 102066183 | 10206618 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | S553 | 20444 | POWDER FOR INFUSION | ||||||||
| 102066183 | 10206618 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 51 NG/KG/MIN | U | T366 | 20444 | 51 | DF | POWDER FOR INFUSION | |||||
| 102066183 | 10206618 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 52 NG/KG/MIN, CO | U | Z880 | 20444 | 52 | DF | POWDER FOR INFUSION | |||||
| 102066183 | 10206618 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | U | 0 | SOLUTION FOR INJECTION | ||||||||||
| 102066183 | 10206618 | 6 | C | LETAIRIS | AMBRISENTAN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102066183 | 10206618 | 1 | Pulmonary arterial hypertension |
| 102066183 | 10206618 | 5 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102066183 | 10206618 | HO |
| 102066183 | 10206618 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102066183 | 10206618 | Blood test abnormal | |
| 102066183 | 10206618 | Dehydration | |
| 102066183 | 10206618 | Headache | |
| 102066183 | 10206618 | Internal haemorrhage | |
| 102066183 | 10206618 | Nasopharyngitis | |
| 102066183 | 10206618 | Pain in extremity | |
| 102066183 | 10206618 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102066183 | 10206618 | 1 | 19990709 | 0 | ||
| 102066183 | 10206618 | 2 | 19990709 | 0 |